Eli Lilly tops growth factor grades among S&P healthcare holdings
Source: SeekingAlpha
2026-03-12 16:31:13 ET
More on healthcare stocks
- Eli Lilly Reaching For Peak GLP-1 Euphoria: Rotten Trading Momentum Since November
- Eli Lilly: The Weight-Loss Craze Isn't Over
- CagriSema Incident: The Surprise Winner And What It Means For The Novo-Lilly Rivalry
- Eli Lilly warns of safety risks from compounded obesity drugs after finding impurity
- Energy surges to the top as long-only investors rebalance portfolios: BofA Research
Read the full article on Seeking Alpha
For further details see:
Eli Lilly tops growth factor grades among S&P healthcare holdings
Gilead Sciences Inc.
NASDAQ: GILD
GILD Trading
-2.34% G/L:
$137.745 Last:
3,497,328 Volume:
$140.43 Open:
GILD Latest News
March 19, 2026 10:00:00 am
Combination Therapies Reshape Oncology: A $748B Market Shifts Standard of Care
March 03, 2026 09:00:00 am
Immunotherapy Delivers Across Tumor Types as Oncology Market Eyes $750 Billion
GILD Stock Data
$185,419,569,657
1,228,272,827
0.07%
1237
N/A
Pharmaceuticals
Healthcare
US
Foster City
